Evidence map›Paper›PMID 23174261›Full record

ArticleThe Journal of urology2013

Protamine sulfate induced bladder injury protects from distention induced bladder pain.

Kristina M Stemler, Lara W Crock, H Henry Lai, Jason C Mills, Robert W Gereau, Indira U Mysorekar

Open access · greenAbstract read
In one paragraph

Article in The Journal of urology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
3.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 35 citations in OpenAlex.

  1. Review
  2. Article
  3. UropathogenicFrontiers in cellular and infection microbiology · 2024
    Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. LysMD3 is a type II membrane protein without anThe Journal of biological chemistry · 2018
    Article
  13. Potential of Endocannabinoids to Control Bladder Pain.Frontiers in systems neuroscience · 2018
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Kristina M StemlerDepartment of Obstetrics and Gynecology, Washington University School of Medicine, St. Louis, Missouri 63110, USA.
Lara W Crock
H Henry Lai
Jason C Mills
Robert W Gereau
Indira U Mysorekar
Washington University in St. Louis · US

Funding

Washington University Center for Cellular ImagingP30CA091842 · NCI · WASHINGTON UNIVERSITY · PI TIMOTHY J. EBERLEIN · 2001 to 2026
$128.0M
Washington University DDRCC Supplemental Equipment RequestP30DK052574 · NIDDK · WASHINGTON UNIVERSITY · PI Nicholas O. Davidson · 2000 to 2026
$30.8M
Washington University MAPP Network Discovery SiteU01DK082315 · NIDDK · WASHINGTON UNIVERSITY · PI LAI, HING HUNG HENRY · 2008 to 2021
$9.0M
Washington University Center for Translational NeuroscienceP30NS057105 · NINDS · WASHINGTON UNIVERSITY · PI HOLTZMAN, DAVID M. · 2006 to 2011
$8.7M
MECHANISMS OF CENTRAL SENSITIZATIONR01NS048602 · NINDS · WASHINGTON UNIVERSITY · PI GEREAU, ROBERT W · 2004 to 2014
$4.2M
MOLECULAR REGULATION OF GASTRIC CHIEF (ZYMOGENIC) CELL DIFFERENTIATIONR01DK079798 · NIDDK · WASHINGTON UNIVERSITY · PI MILLS, JASON C · 2008 to 2012
$1.6M
Mechanisms of epithelial renewal in normal and diseased urinary bladderR00DK080643 · NIDDK · WASHINGTON UNIVERSITY · PI MYSOREKAR, INDIRA U · 2009 to 2011
$747k
Mechanisms of Central SensitizationR56NS048602 · NINDS · WASHINGTON UNIVERSITY · PI GEREAU, ROBERT W · 2017 to 2017
$533k
Mechanisms of epithelial renewal in normal and diseased urinary bladderK99DK080643 · NIDDK · WASHINGTON UNIVERSITY · PI MYSOREKAR, INDIRA U · 2007 to 2008
$167k
The Role of Metabotropic Glutamate Receptor 5 in Bladder PainF30DK089969 · NIDDK · WASHINGTON UNIVERSITY · PI CROCK, LARA WILEY · 2010 to 2012
$80k
NCI NIH HHS P30 CA091842NCI NIH HHS P30 CA91842NIDDK NIH HHS DK079798NIDDK NIH HHS DK080643NIDDK NIH HHS DK089969NIDDK NIH HHS DK82315NIDDK NIH HHS F30 DK089969NIDDK NIH HHS K99 DK080643NIDDK NIH HHS P30 DK052574NIDDK NIH HHS P30 DK052574-12NIDDK NIH HHS R00 DK080643NIDDK NIH HHS R01 DK079798NIDDK NIH HHS U01 DK082315NINDS NIH HHS NS48602NINDS NIH HHS P30 NS057105NINDS NIH HHS R01 NS048602NINDS NIH HHS R56 NS048602
6 · The paper itself

Abstract

purposeBladder pain is a debilitating symptom of many urological conditions. There is no generally effective treatment. Abnormal urothelial turnover is common to multiple disease states but the specific components of urothelial injury and the resulting molecular signals that lead to bladder pain are unknown. We examined mouse models of bladder injury induced by uropathogenic Escherichia coli, protamine sulfate (Sigma®) and bacterial lipopolysaccharide to identify cellular and molecular correlates underlying pain sensitization in response to the stimuli. MATERIALS AND

methodsC57BL/6 female mice (Jackson Laboratory, Bar Harbor, Maine) were given intravesicular protamine sulfate, lipopolysaccharide or uropathogenic E. coli. The impact of each on nociception was determined by measuring the evoked visceromotor response to bladder distention 24 hours after inoculation. Levels of pyuria and tissue inflammation were examined by urinary cytology and tissue histology. Quantitative polymerase chain reaction and gene expression analysis were used to identify injury profiles associated with nociception.

resultsProtamine sulfate treatment was significantly analgesic upon bladder distention. Protamine treated bladders did not show pyuria or extensive tissue damage. Protamine injury was associated with a global decrease in the expression of inflammation associated genes. In contrast, uropathogenic E. coli injury significantly increased the nociceptive response to bladder distention. Lipopolysaccharide treatment did not affect nociception. Finally, injury induced expression of inflammation associated genes correlated with nociceptive responses.

conclusionsProtamine treatment of the bladder is analgesic and tissue protective, and it suppresses the inflammatory cytokine expression normally associated with nociception. Also, the injury modalities that result in differential tissue response patterns provide an innovative method for identifying mediators of visceral pain.

Indexed as

Urinary BladderAnimalsFemaleMiceMice, Inbred C57BLProtaminesUrinary Bladder DiseasesVisceral PainProtamines

Identifiers

PMID23174261
PMCPMC3662487
OpenAlexW2114016749

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.